Patents Assigned to ALPHALA CO., LTD.
  • Patent number: 11384060
    Abstract: Disclosed are compounds of formula (I) below and pharmaceutically acceptable salts thereof: (I), in which each of variables R1, R2, R3, R4, R5, A1, A2, A3, A4, X and Y is defined herein. Also disclosed are methods for reducing the glycemic level and treating glucagon-associated disorders with a compound of formula (I) or a salt thereof and a pharmaceutical composition containing same.
    Type: Grant
    Filed: January 22, 2018
    Date of Patent: July 12, 2022
    Assignee: ALPHALA CO., LTD.
    Inventors: Cheng-Ho Chung, Shi-Liang Tseng, Yung-Ning Yang, Yen-Fu Chen
  • Patent number: 11174253
    Abstract: Disclosed are compounds of formula (I) below and pharmaceutically acceptable salts thereof: Formula (I), in which each of variables L, R3, R4, Y, Z1, Z2 and Z3 is defined herein. Also disclosed is a method for treating a cancer with a compound of formula (I) or a salt thereof and a pharmaceutical composition containing same.
    Type: Grant
    Filed: August 1, 2018
    Date of Patent: November 16, 2021
    Assignee: ALPHALA CO., LTD.
    Inventors: Cheng-Ho Chung, Shi-Liang Tseng, Yen-Fu Chen, Jian-Bin Lee
  • Patent number: 10882837
    Abstract: Disclosed are compounds of formula (I) below and pharmaceutically acceptable salts thereof, in which each of variables R1, R2, L, and Z is defined herein. Also disclosed are methods for reducing the glycemic level and treating glucagon-associated disorders with a compound of formula (I) or a salt thereof and a pharmaceutical composition containing same.
    Type: Grant
    Filed: January 22, 2018
    Date of Patent: January 5, 2021
    Assignee: ALPHALA CO., LTD.
    Inventors: Cheng-Ho Chung, Shi-Liang Tseng, Yung-Ning Yang, Yen-Fu Chen